SCHEMBL19445611

SCHEMBL19445611

COc1ccc(N)cc1C(=O)NCC(=O)Nc1ccc(OC)c(C(=O)N[C@@H](CCCCN)C(=O)Nc2ccc(OC)c(C(=O)N[C@H](C=O)CCCCN)c2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.38
▸ TERT O14746 1/20 0.38
▸ KLKB1 P03952 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.35
▸ MMP2 P08253 4/20 0.35
▸ PSMB11 A5LHX3 1/20 0.34
▸ PSMA7 O14818 1/20 0.34
▸ PSMB1 P20618 1/20 0.34
▸ PSMA1 P25786 1/20 0.34
▸ PSMA2 P25787 1/20 0.34
▸ PSMA3 P25788 1/20 0.34
▸ PSMA4 P25789 1/20 0.34
▸ PSMB8 P28062 1/20 0.34
▸ PSMB9 P28065 1/20 0.34
▸ PSMA5 P28066 1/20 0.34
▸ PSMB4 P28070 1/20 0.34
▸ PSMB6 P28072 1/20 0.34
▸ PSMB5 P28074 1/20 0.34
▸ PSMB10 P40306 1/20 0.34
▸ PSMB3 P49720 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19445603 0.94 KLKB1 (0.39) KLKB1MMP2TSHRERAP2HDAC4
SCHEMBL19445810 0.86 KCNB1 (0.40) KLKB1MMP2TSHRERAP2LNPEP
SCHEMBL19445641 0.85 ERAP2 (0.44) TERTKLKB1MMP2ERAP2LNPEP
SCHEMBL19445879 0.85 KCNK3 (0.41) NPC1KLKB1MMP2TSHRKCNB1
SCHEMBL19445834 0.84 MMP2 (0.39) KLKB1MMP2TSHRKCNB1HDAC1
SCHEMBL12515368 0.83 KLKB1 (0.41) KLKB1MMP2TSHRERAP2HDAC4
SCHEMBL19445616 0.83 ALDH1A1 (0.40) ALDH1A1
SCHEMBL19445764 0.83 KLKB1 (0.40) KLKB1MMP2TSHRERAP2HDAC4
SCHEMBL19445715 0.82 KLKB1 (0.41) KLKB1MMP2TSHRERAP2HDAC4
SCHEMBL21371597 0.82 KLKB1 (0.41) KLKB1MMP2TSHRERAP2HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2709619-B1 COMPOUNDS FOR USE IN TREATMENT OF MUCOSITIS CELLCEUTIX CORP (US) 2017-10-11 — — EP disclosed
Send feedback